NURECA
Back to All Ratios
|
NURECA Last 5 Year Working Capital/Sales History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Working Capital/Sales(x) | 0.66 | 1.39 | 1.39 | 4.28 | 8.30 |
What is the latest Working Capital/Sales ratio of NURECA ?
Year | Working Capital/Sales |
---|---|
Mar2023 | 0.66 |
Mar2022 | 1.39 |
Mar2021 | 1.39 |
Mar2020 | 4.28 |
Mar2019 | 8.30 |
How is Working Capital/Sales of NURECA Trending?
Years | Working Capital/Sales | % Change | |
---|---|---|---|
Mar2023 | 0.66 | -52.52 | |
Mar2022 | 1.39 | 0.00 | |
Mar2021 | 1.39 | -67.52 | |
Mar2020 | 4.28 | -48.43 | |
Mar2019 | 8.3 | - |
Other Financial Ratios of NURECA
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Working Capital/Sales ratio of peers of NURECA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NURECA | ₹288.6 Cr | -1.6% | 6.9% | -15.1% | Stock Analytics | |
POLY MEDICURE | ₹15,747.5 Cr | 5.4% | 3.6% | 69.4% | Stock Analytics | |
PREVEST DENPRO | ₹492.1 Cr | -6.1% | 21.7% | 25.5% | Stock Analytics |
NURECA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NURECA | -1.6% |
6.9% |
-15.1% |
SENSEX | 1% |
2.8% |
23.9% |
You may also like the below Video Courses